15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35447344 | The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase. | 2022 Jul 1 | 1 |
2 | 34281458 | Design, synthesis, and evaluation of 3,7-substituted coumarin derivatives as multifunctional Alzheimer's disease agents. | 2021 Dec | 1 |
3 | 30108930 | Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease. | 2018 Feb 1 | 3 |
4 | 26999091 | Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif. | 2016 Mar 17 | 1 |
5 | 27396685 | Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors. | 2016 Oct 15 | 1 |
6 | 23211968 | Synthesis and biological evaluation of novel propargyl amines as potential fluorine-18 labeled radioligands for detection of MAO-B activity. | 2013 Jan 1 | 3 |
7 | 23908775 | Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential. | 2010 Jul | 1 |
8 | 18035186 | Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. | 2007 Sep | 1 |
9 | 18488080 | Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. | 2007 Jun | 1 |
10 | 16675649 | Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease. | 2006 May 15 | 2 |
11 | 17017568 | Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. | 2006 | 1 |
12 | 16027398 | Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. | 2005 Aug | 2 |
13 | 14696044 | Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? | 2004 Jan | 2 |
14 | 7931256 | Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. | 1994 | 1 |
15 | 8469735 | [An increase in the radioprotective effect of O-methyltyramine and mezaton by monoamine oxidase inhibitors]. | 1993 Jan-Feb | 1 |